Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors

被引:5
|
作者
Dall'Olio, R [1 ]
Gaggi, R [1 ]
Voltattorni, M [1 ]
Tanda, A [1 ]
Gandolf, O [1 ]
机构
[1] Univ Bologna, Dept Pharmacol, I-40126 Bologna, Italy
来源
BEHAVIOURAL PHARMACOLOGY | 2002年 / 13卷 / 08期
关键词
nafadotride; 7-OH-DPAT; quinpirole; apomorphine; SKF; 38393; locomotor activity; stereotypies; grooming behavior; rat;
D O I
10.1097/00008877-200212000-00004
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The administration of nafadotride, given at doses known to block the D-3 dopamine receptors (0.75, 1.5, 3 mg/kg i.p.) increased locomotor activity both in naive and habituated rats and counteracted the hypothermia but not the hypomotility induced by a low dose of the putative D-3 dopamine agonist (+/-)-7-hydroxy-2-(di-N-propylamino)-tetralin (7-OH-DPAT; 0.04 mg/kg). Nafadotride did not antagonize either the motor effects induced by different doses of the D-2 agonist quinpirole (0.05 and 0.3 mg/kg) or the hypermotility induced by 7-OH-DPAT given at a dose (0.32 mg/kg) stimulating D-2 dopamine receptors. The same nafadotride doses potentiated the grooming behavior induced by the D-1 dopamine agonist SKF 38393 (10 mg/kg i.p.) as well as the stereotyped response to the D-1/D-2 agonist apomorphine (0.5 mg/kg s.c.). Stereotyped behavior was also observed in rats concomitantly treated with nafadotride and the D-2 agonist quinpirole. As the activation of D-1 dopamine receptors plays an important role in the occurrence of stereotypies, the results suggest that the blockade of D-3 receptors by nafadotride could have favored D-1/D-2 dopamine receptor-mediated behaviors by potentiating D-1 receptor function. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:633 / 638
页数:6
相关论文
共 50 条
  • [1] D1 AND D2 DOPAMINE RECEPTOR MECHANISMS IN DOPAMINERGIC BEHAVIORS
    KOLLER, WC
    HERBSTER, G
    CLINICAL NEUROPHARMACOLOGY, 1988, 11 (03) : 221 - 231
  • [2] DOPAMINE D1/D2 RECEPTOR INTERACTION
    SASA, M
    AKAIKE, A
    OHNO, Y
    HARA, M
    TAKAORI, S
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1991, 45 (02): : 507 - 510
  • [3] Reversal of methamphetamine sensitization by repeated administration of dopamine D1 receptor agonism: Effect on the affinity of dopamine D1 and D2 receptor
    Shuto, Takahide
    Seeman, Philip
    Nishi, Akinciri
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 189P - 189P
  • [4] A D1/D2 CHIMERIC DOPAMINE RECEPTOR MEDIATES A D1 RESPONSE TO A D2-SELECTIVE AGONIST
    MACKENZIE, RG
    STEFFEY, ME
    MANELLI, AM
    POLLOCK, NJ
    FRAIL, DE
    FEBS LETTERS, 1993, 323 (1-2) : 59 - 62
  • [5] Evidence against dopamine D1/D2 receptor heteromers
    Frederick, A. L.
    Yano, H.
    Trifilieff, P.
    Vishwasrao, H. D.
    Biezonski, D.
    Meszaros, J.
    Urizar, E.
    Sibley, D. R.
    Kellendonk, C.
    Sonntag, K. C.
    Graham, D. L.
    Colbran, R. J.
    Stanwood, G. D.
    Javitch, J. A.
    MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1373 - 1385
  • [6] DOPAMINE RECEPTOR SUBTYPES - BEYOND THE D1/D2 CLASSIFICATION
    ANDERSEN, PH
    GINGRICH, JA
    BATES, MD
    DEARRY, A
    FALARDEAU, P
    SENOGLES, SE
    CARON, MG
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (06) : 231 - 236
  • [7] Constitutive activity of a chimeric D2/D1 dopamine receptor
    Kozell, LB
    Neve, KA
    MOLECULAR PHARMACOLOGY, 1997, 52 (06) : 1137 - 1149
  • [8] Dopamine D1–D2 receptor heterodimers: A literature review
    Vekshina N.L.
    Anokhin P.K.
    Veretinskaya A.G.
    Shamakina I.Y.
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2017, 11 (2) : 111 - 119
  • [9] Adolescent Maturation of D1 and D2 Dopamine Receptor Interactions
    Dwyer, Jennifer Buenzle
    Martinez, Lesly
    Ganddini, Gabriela
    Perez, Mayra
    Leslie, Frances M.
    FASEB JOURNAL, 2010, 24
  • [10] Evidence against dopamine D1/D2 receptor heteromers
    A L Frederick
    H Yano
    P Trifilieff
    H D Vishwasrao
    D Biezonski
    J Mészáros
    E Urizar
    D R Sibley
    C Kellendonk
    K C Sonntag
    D L Graham
    R J Colbran
    G D Stanwood
    J A Javitch
    Molecular Psychiatry, 2015, 20 : 1373 - 1385